Mueller AR et al. |
Severe neurotoxicity after liver transplantation: association between FK 506 therapy and hepatitis C virus disease. |
1994 |
Transplant. Proc. |
pmid:7527951
|
Platz KP et al. |
Causes of death following liver transplantation in FK 506- and cyclosporine-treated patients. |
1994 |
Transplant. Proc. |
pmid:7527952
|
Christe W |
Neurological disorders in liver and kidney transplant recipients. |
1994 |
Transplant. Proc. |
pmid:7527953
|
Meiser BM and Reichart B |
New trends in clinical immunosuppression. |
1994 |
Transplant. Proc. |
pmid:7527954
|
Tze WJ et al. |
Immunohistochemical studies of pig islet xenograft in rats immunosuppressed with FK 506. |
1994 |
Transplant. Proc. |
pmid:7513470
|
Hara Y et al. |
Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression. |
1994 |
Transplant. Proc. |
pmid:7527955
|
Tze WJ et al. |
Prolongation of pig islet xenograft survival in rats by local immunosuppression with FK 506. |
1994 |
Transplant. Proc. |
pmid:7513471
|
Guy S et al. |
Immunosuppression conversion for relief of side effects. |
1994 |
Transplant. Proc. |
pmid:7527956
|
Fukuzaki T et al. |
Nonvascularized islet xenograft rejection in a mouse-to-rat combination where the vascularized heart is rapidly rejected. |
1994 |
Transplant. Proc. |
pmid:7513472
|
Knoop C et al. |
FK 506 rescue therapy for irreversible airway rejection in heart-lung transplant recipients: report on five cases. |
1994 |
Transplant. Proc. |
pmid:7527957
|
Ohtsuka S et al. |
Hamster-to-rat xenotransplantation of whole pancreas by FK 506 combined with splenectomy. |
1994 |
Transplant. Proc. |
pmid:7513473
|
Candinas D et al. |
Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation. |
1994 |
Transplant. Proc. |
pmid:7527959
|
Iwata H et al. |
Suppression of allograft responses by combining alloantigen-specific i.v. presensitization with suboptimal doses of FK 506 or rapamycin. |
1994 |
Transplant. Proc. |
pmid:7513476
|
Nomoto S et al. |
Cardiotoxicity of long-term intravenous administration of FK506 in rabbits: dose relationship and recovery after discontinuance. |
1994 |
Transplant. Proc. |
pmid:7513477
|
Kato H et al. |
Spontaneous proliferation of peripheral blood mononuclear cells as an indicator for insufficient plasma levels of FK 506 in the early phase after liver transplantation. |
1994 |
Transplant. Proc. |
pmid:7513481
|
Nishikawa K et al. |
Experimental studies of vascularized joint allografts in rats. |
1994 |
Transplant. Proc. |
pmid:7513482
|
Moudgil A et al. |
Inhibition of in vitro immunoglobulin production by a novel immunosuppressive drug brequinar sodium. |
1994 |
Transplant Sci |
pmid:7528627
|
Mazariegos GV et al. |
Rubella infection after orthotopic liver transplantation. |
1994 |
Pediatr. Infect. Dis. J. |
pmid:7514783
|
Klaus GG et al. |
Properties of mouse CD40. Ligation of CD40 activates B cells via a Ca(++)-dependent, FK506-sensitive pathway. |
1994 |
Eur. J. Immunol. |
pmid:7528676
|
Mañez R et al. |
Fluconazole therapy in transplant recipients receiving FK506. |
1994 |
Transplantation |
pmid:7515201
|
Tzakis AG et al. |
Intestinal transplantation. |
1994 |
Annu. Rev. Med. |
pmid:7515221
|
Foster CA et al. |
Pharmacological modulation of endothelial cell-associated adhesion molecule expression: implications for future treatment of dermatological diseases. |
1994 |
J. Dermatol. |
pmid:7531725
|
Mulkey RM et al. |
Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression. |
1994 |
Nature |
pmid:7515479
|
Douglas CM et al. |
The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-beta-D-glucan synthase. |
1994 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7528927
|
Breuder T et al. |
Calcineurin is essential in cyclosporin A- and FK506-sensitive yeast strains. |
1994 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7515500
|
Lhoëst G et al. |
Isolation and identification of a FK-506 C36-C37 dihydrodiol from erythromycin-induced rabbit liver microsomes. |
1994 |
J Pharm Biomed Anal |
pmid:7516189
|
Kraus-Friedmann N and Feng L |
Reduction of ryanodine binding and cytosolic Ca2+ levels in liver by the immunosuppressant FK506. |
1994 |
Biochem. Pharmacol. |
pmid:7529023
|
Ohtsuka S et al. |
Experimental rat pancreas transplant: surgical technique and immunological considerations. |
1994 |
Surg. Today |
pmid:7516209
|
Hisatomi K et al. |
Limited effectiveness of FK506 administration for ongoing rejection in heterotopic rat heart transplantation. |
1994 |
Surg. Today |
pmid:7516210
|
Wolter K et al. |
Interaction between FK 506 and clarithromycin in a renal transplant patient. |
1994 |
Eur. J. Clin. Pharmacol. |
pmid:7532134
|
Konishi M et al. |
Effects of FK506 on surface antigen expression by regenerating thymocytes after sublethal irradiation in the rat. |
1994 |
Thymus |
pmid:7532330
|
Nardo B et al. |
Pretransplant xenogeneic blood transfusion combined with FK 506 prolongs hamster-to-rat liver xenograft survival. |
1994 |
Transplant. Proc. |
pmid:7518112
|
Pan F et al. |
FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts. |
1994 |
Transplant. Proc. |
pmid:7518113
|
Raymond M et al. |
Functional expression of P-glycoprotein in Saccharomyces cerevisiae confers cellular resistance to the immunosuppressive and antifungal agent FK520. |
1994 |
Mol. Cell. Biol. |
pmid:7505392
|
Valdivia LA et al. |
Complement and target cells belong to the same species after liver xenografting: protection from hyperacute rejection. |
1994 |
Transplant. Proc. |
pmid:7518123
|
Hayashi S et al. |
Synergistic effect of donor pretreatment using FK 506 in hamster-to-rat cardiac xenotransplantation. |
1994 |
Transplant. Proc. |
pmid:7518126
|
Ohtsuka S et al. |
Mechanism of antibody production in guinea pig to rat discordant xenotransplant: establishment of a simple model by intravenous injection of discordant splenocytes. |
1994 |
Transplant. Proc. |
pmid:7518130
|
Todo S et al. |
Intestinal transplantation at the University of Pittsburgh. |
1994 |
Transplant. Proc. |
pmid:7518136
|
Reyes J et al. |
Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. |
1994 |
Transplant. Proc. |
pmid:7518137
|
Murase N et al. |
Small bowel transplantation in sensitized recipients: comparison with heart, kidney, and liver grafts. |
1994 |
Transplant. Proc. |
pmid:7518139
|
Pruschy MN et al. |
Mechanistic studies of a signaling pathway activated by the organic dimerizer FK1012. |
1994 |
Chem. Biol. |
pmid:9383386
|
Frizell E et al. |
FK506 enhances fibrogenesis in in vitro and in vivo models of liver fibrosis in rats. |
1994 |
Gastroenterology |
pmid:7518783
|
Fujimura A and Ebihara A |
Administration time-dependent toxicity of a new immunosuppressive agent, tacrolimus (FK 506). |
1994 |
Life Sci. |
pmid:7518886
|
Gottschalk AR et al. |
Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2. |
1994 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7518929
|
Prasad TN et al. |
FK 506 (Tacrolimus) metabolism by rat liver microsomes and its inhibition by other drugs. |
1994 |
Res. Commun. Chem. Pathol. Pharmacol. |
pmid:7518966
|
Dumont FJ et al. |
Quantitative and temporal analysis of the cellular interaction of FK-506 and rapamycin in T-lymphocytes. |
1994 |
J. Pharmacol. Exp. Ther. |
pmid:7507994
|
Mueller AR et al. |
Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506. |
1994 |
Transplantation |
pmid:7518974
|
Platz KP et al. |
Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506. |
1994 |
Transplantation |
pmid:7518975
|
Cakaloglu Y et al. |
Importance of cytochrome P-450IIIA activity in determining dosage and blood levels of FK 506 and cyclosporine in liver transplant recipients. |
1994 |
Hepatology |
pmid:7519161
|
Luan S et al. |
Light-regulated, tissue-specific immunophilins in a higher plant. |
1994 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7508125
|
Blazar BR et al. |
FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation. |
1994 |
J. Immunol. |
pmid:7519216
|
Andoh TF et al. |
Enhancement of FK506 nephrotoxicity by sodium depletion in an experimental rat model. |
1994 |
Transplantation |
pmid:7509514
|
Ota K |
Living donor kidney transplantation in Japan. |
1994 |
Transplant. Proc. |
pmid:7520622
|
Bäckman L et al. |
FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects. |
1994 |
Transplantation |
pmid:7509516
|
Hirose M and Kuroda Y |
Reinforcement of cyclosporin A-induced red cell destruction by superoxide. |
1994 |
Tokushima J. Exp. Med. |
pmid:7535479
|
Takahara S et al. |
Monitoring of FK 506 blood levels in kidney transplant recipients. |
1994 |
Transplant. Proc. |
pmid:7520623
|
Kitamura Y et al. |
Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice. |
1994 |
J. Neuroimmunol. |
pmid:7509816
|
Sun CK et al. |
Intensive care after orthotopic liver transplantation. |
1994 |
Transplant. Proc. |
pmid:7520627
|
Sato K et al. |
Effectiveness of triple regimen immunosuppression in canine pancreatic allotransplantation. |
1994 |
Transplant. Proc. |
pmid:7520628
|
Tze WJ et al. |
Successful islet allotransplantation in diabetic rats immunosuppressed with FK506: a functional and immunological study. |
1994 |
Metab. Clin. Exp. |
pmid:7510012
|
Thomson AW |
Immunosuppressive drugs and the induction of transplantation tolerance. |
1994 |
Transpl. Immunol. |
pmid:7535641
|
Oishi M et al. |
Successful swine small bowel transplantation using FK506: effect on endotoxin translocation. |
1994 |
Transplant. Proc. |
pmid:7520629
|
Yamauchi T |
[Multiple abdominal organ transplantation in swine using FK-506]. |
1994 |
Nihon Geka Gakkai Zasshi |
pmid:7510015
|
Jiang H et al. |
FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro. |
1994 |
Transplant. Proc. |
pmid:7520631
|
Hara Y et al. |
Heterotopic rat heart transplantation to the iliac vessels. |
1994 |
Transplant. Proc. |
pmid:7520632
|
Nozaki S et al. |
Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients. |
1994 |
Transplant. Proc. |
pmid:7520633
|
Masaoka T |
Problems of bone marrow transplantation in Japan. |
1994 |
Transplant. Proc. |
pmid:7520634
|
Surdacka E et al. |
[New immunosuppressive drugs in transplantation]. |
1994 |
Prz. Lek. |
pmid:7532870
|
Kasiske BL |
The effects of immunosuppressive agents on plasma lipoproteins after organ transplantation. |
1994 |
J. Lab. Clin. Med. |
pmid:7521894
|
Krentz AJ et al. |
Serum lipids and apolipoproteins in liver transplant recipients: a comparative study of cyclosporin A and FK 506. |
1994 |
J. Lab. Clin. Med. |
pmid:7521895
|
Jensen C et al. |
Interaction between tacrolimus and erythromycin. |
1994 |
Lancet |
pmid:7521928
|
Winkler M et al. |
Comparison of different assays for the quantitation of FK 506 levels in blood or plasma. |
1994 |
Ther Drug Monit |
pmid:7521978
|
D'Ambrosio R et al. |
Multicenter comparison of tacrolimus (FK 506) whole blood concentrations as measured by the Abbott IMX analyzer and enzyme immunoassay with methylene chloride extraction. |
1994 |
Ther Drug Monit |
pmid:7521979
|
Metcalfe S et al. |
FK506 and cyclosporin A each inhibit antigen-specific signaling in the T cell line 171 in the absence of a calcium signal. |
1994 |
Cell. Immunol. |
pmid:7522130
|
Krentz AJ et al. |
Tacrolimus (FK506) versus cyclosporin in prevention of liver allograft rejection. |
1994 |
Lancet |
pmid:7523806
|
Collins RH |
Tacrolimus (FK506) versus cyclosporin in prevention of liver allograft rejection. |
1994 |
Lancet |
pmid:7523807
|
Schmidt A et al. |
Two FK506 resistance-conferring genes in Saccharomyces cerevisiae, TAT1 and TAT2, encode amino acid permeases mediating tyrosine and tryptophan uptake. |
1994 |
Mol. Cell. Biol. |
pmid:7523855
|
|
A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. |
1994 |
N. Engl. J. Med. |
pmid:7523946
|
Calne RY |
Immunosuppression in liver transplantation. |
1994 |
N. Engl. J. Med. |
pmid:7523947
|
Schleuning M et al. |
Inhibition of cyclosporin A/FK506 resistant, lymphokine-induced T-cell activation by phenothiazine derivatives. |
1994 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:7523957
|
Perotti BY et al. |
HPLC assay for FK 506 and two metabolites in isolated rat hepatocytes and rat liver microsomes. |
1994 |
Pharm. Res. |
pmid:7524055
|
Mukaida N et al. |
Molecular mechanism of interleukin-8 gene expression. |
1994 |
J. Leukoc. Biol. |
pmid:7525815
|
Hiromatsu Y et al. |
Inhibitory effect of FK506 on intercellular adhesion molecule-1 (ICAM-1) expression on cultured thyroid cells. |
1994 |
Kurume Med J |
pmid:7526029
|
Kinoshita I et al. |
Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. |
1994 |
Muscle Nerve |
pmid:7526208
|
Matsunami H et al. |
New technique for measuring tacrolimus concentrations in blood. |
1994 |
Am J Hosp Pharm |
pmid:7510929
|
Cullen BR and Heitman J |
Human immunodeficiency virus. Chaperoning a pathogen. |
1994 |
Nature |
pmid:7526224
|
Renoir JM et al. |
Effects of immunosuppressants FK506 and rapamycin on the heterooligomeric form of the progesterone receptor. |
1994 |
J. Steroid Biochem. Mol. Biol. |
pmid:7510997
|
Connolly JO et al. |
Renal arteriopathy associated with FK 506 therapy following liver transplantation. |
1994 |
Nephrol. Dial. Transplant. |
pmid:7526278
|
Pham SM et al. |
Cardiac transplantation at the University of Pittsburgh: 1994 update. |
1994 |
Clin Transpl |
pmid:7547531
|
Radanyi C et al. |
The ability of the immunophilin FKBP59-HBI to interact with the 90-kDa heat shock protein is encoded by its tetratricopeptide repeat domain. |
1994 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7526392
|
Abu-Elmagd K et al. |
Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience. |
1994 |
Clin Transpl |
pmid:7547533
|
Ericzon B et al. |
Glucose metabolism in liver transplant recipients treated with FK 506 or cyclosporin in the European multicentre study. |
1994 |
Transpl. Int. |
pmid:11271178
|
Ayres RC et al. |
Peripheral neurotoxicity with tacrolimus. |
1994 |
Lancet |
pmid:7511197
|
Ko S et al. |
The pharmacokinetic benefits of newly developed liposome-incorporated FK506. |
1994 |
Transplantation |
pmid:7526494
|
Shapiro R et al. |
Renal transplantation at the University of Pittsburgh: the impact of FK506. |
1994 |
Clin Transpl |
pmid:7547544
|
Undre N and Möller A |
Pharmacokinetic interpretation of FK 506 levels in blood and in plasma during a European randomised study in primary liver transplant patients. The FK 506 European Study Group. |
1994 |
Transpl. Int. |
pmid:11271189
|
Bendahan J et al. |
The effect of administration of FK506 on delayed regeneration in flushed partially hepatectomized livers. |
1994 |
Transplantation |
pmid:7511255
|
Chavin KD et al. |
Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance. |
1994 |
Transplantation |
pmid:7511258
|
Yano S et al. |
Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes. |
1994 |
Jpn. J. Cancer Res. |
pmid:7511575
|
Iwata H et al. |
Suppression of allograft responses by combining alloantigen-specific i.v. pre-sensitization with suboptimal doses of rapamycin. |
1994 |
Int. Immunol. |
pmid:7511931
|